Clinical Trials · NCT01613495

Ghrelin Suppression by Octreotide in Prader-Willi

Phase
N/A
Recruitment status
Unknown
Sponsor
Oregon Health and Science University
Enrollment
2
Start date
Aug 2005
Locations
See registry
Primary endpoint
Ghrelin levels
View Octreotide compound reference